Indications
Therapeutic Asset Ratings
18,140 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
(+)-Vincristine
Myelodysplastic Syndrome With Excess Blasts
Roswell Park Cancer Institute
P2
B
(63)
(+)-Vincristine
Wilms Tumor
Centre Oscar Lambret
P2
B
(63)
Vinorelbine Ditartrate
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
P2
B
(63)
Vismodegib
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
P2
B
(63)
Vorinostat
Giant Cell Glioblastoma
National Cancer Institute (NCI)
P2
B
(63)
Vorinostat
Adult Glioblastoma
National Cancer Institute (NCI)
P2
B
(63)
Vorinostat
Gliosarcoma
National Cancer Institute (NCI)
P2
B
(63)
Adriamycin
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
Li Zhiming
P2/3
B
(63)
Adriamycin
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
University of Washington
P2/3
B
(63)
Adriamycin
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)
P2/3
B
(63)
Adriamycin
Intravascular Large B-Cell Lymphoma
Northwestern University
P2/3
B
(63)
Adriamycin
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)
P2/3
B
(63)
Adriamycin
T-Cell/Histiocyte Rich Large B Cell Lymphoma
Ruijin Hospital
P2/3
B
(63)
Arsenic Trioxide
Myelodysplastic Syndrome
The University of Hong Kong
P2/3
B
(63)
Busulfanum
Fucosidosis
Masonic Cancer Center, University of Minnesota
P2/3
B
(63)
Busulfanum
Metachromatic Leukodystrophy
Masonic Cancer Center, University of Minnesota
P2/3
B
(63)
Capecitabine
Peritoneal Carcinomatosis
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
P2/3
B
(63)
Carboplatin
Cancer
Qilu Pharmaceutical Co., Ltd.
P2/3
B
(63)
Carboplatin
Gastroesophageal Cancer
Iambic Therapeutics, Inc
P1/2
B
(63)
Cediranib
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)
P2/3
B
(63)
Cis-Diamminedichloroplatinum Ii
Pancreatic Adenocarcinoma
Jonsson Comprehensive Cancer Center
P2/3
B
(63)
Cyclophosphamide
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
Li Zhiming
P2/3
B
(63)
Cyclophosphamide
Intravascular Large B-Cell Lymphoma
Mayo Clinic
P2/3
B
(63)
Cyclophosphamide
Thalassemia
Memorial Sloan Kettering Cancer Center
P2/3
B
(63)
Encorafenib
Colon Adenocarcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
P2/3
B
(63)
Showing 3001 to 3025 of 18,140 assets
Previous
Page 121 of 726
Next